QSC timeline
Every QSC batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| QSC-2607-C6970 | Triptorelin | 22 Jul 2026 | 2026-Q3 | 1 | 99.92 | n<2 | 99.90 | -0.02 | |
| QSC-2606-V8637 | CJC-1295 (no DAC) | 17 Jun 2026 | 2026-Q3 | 4 | 99.93 | 0.68 | 99.90 | -0.03 | |
| QSC-2605-A7936 | GHRP-6 | 31 May 2026 | 2026-Q2 | 2 | 99.93 | 0.00 | 99.90 | -0.03 | |
| QSC-2605-E6873 | SS-31 (Elamipretide) | 27 May 2026 | 2026-Q2 | 2 | 99.46 | 0.40 | 99.90 | +0.44 | |
| QSC-2605-W8602 | Liraglutide | 01 May 2026 | 2026-Q3 | 5 | 99.32 | 0.71 | 99.23 | -0.09 | |
| QSC-2604-R7865 | Enclomiphene citrate | 28 Apr 2026 | 2026-Q2 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| QSC-2604-H9231 | Semaglutide | 04 Apr 2026 | 2026-Q2 | 5 | 99.32 | 0.97 | 99.79 | +0.47 | |
| QSC-2602-L8571 | Semaglutide | 28 Feb 2026 | 2026-Q1 | 3 | 99.41 | 1.16 | 99.90 | +0.49 | |
| QSC-2602-W8804 | Ipamorelin | 23 Feb 2026 | 2026-Q1 | 11 | 99.78 | 0.85 | 99.90 | +0.12 | |
| QSC-2602-G8557 | Semaglutide | 20 Feb 2026 | 2026-Q1 | 4 | 98.92 | 0.78 | 99.11 | +0.19 | |
| QSC-2602-E9474 | CJC-1295 with DAC | 17 Feb 2026 | 2026-Q3 | 11 | 99.06 | 1.03 | 99.69 | +0.63 | |
| QSC-2602-P9435 | Exenatide | 08 Feb 2026 | 2026-Q2 | 7 | 98.94 | 1.03 | 99.30 | +0.36 | |
| QSC-2602-V8219 | Pinealon | 04 Feb 2026 | 2026-Q2 | 4 | 99.92 | 0.10 | 99.90 | -0.02 | |
| QSC-2601-N9656 | Hexarelin | 12 Jan 2026 | 2026-Q2 | 7 | 99.74 | 0.27 | 99.90 | +0.16 | |
| QSC-2601-N8430 | Selank | 12 Jan 2026 | 2026-Q1 | 9 | 99.93 | 0.54 | 99.90 | -0.03 | |
| QSC-2601-V7307 | TB-500 | 11 Jan 2026 | 2026-Q2 | 1 | 99.54 | n<2 | 99.90 | +0.36 | |
| QSC-2601-B7339 | CJC-1295 (no DAC) | 11 Jan 2026 | 2026-Q2 | 3 | 98.88 | 0.16 | 99.54 | +0.66 | |
| QSC-2512-G6894 | CJC-1295 with DAC | 23 Dec 2025 | 2026-Q1 | 10 | 98.84 | 1.20 | 99.27 | +0.43 | |
| QSC-2512-D7108 | Dihexa | 07 Dec 2025 | 2026-Q2 | 6 | 99.32 | 0.95 | 99.90 | +0.58 | |
| QSC-2511-W8801 | PT-141 (Bremelanotide) | 21 Nov 2025 | 2025-Q4 | 1 | 99.85 | n<2 | 99.90 | +0.05 | |
| QSC-2511-M9226 | Semaglutide | 20 Nov 2025 | 2026-Q2 | 17 | 99.44 | 0.84 | 99.90 | +0.46 | |
| QSC-2511-T6680 | Pramlintide | 19 Nov 2025 | 2026-Q1 | 10 | 99.13 | 1.70 | 99.82 | +0.69 | |
| QSC-2511-R6913 | TB-500 | 14 Nov 2025 | 2026-Q1 | 2 | 99.82 | 0.23 | 99.70 | -0.12 | |
| QSC-2511-N8732 | BPC-157 | 09 Nov 2025 | 2026-Q2 | 15 | 99.93 | 0.24 | 99.90 | -0.03 | |
| QSC-2511-N7625 | Tirzepatide | 09 Nov 2025 | 2026-Q1 | 2 | 99.10 | 0.96 | 99.86 | +0.76 | |
| QSC-2511-S7989 | Tirzepatide | 02 Nov 2025 | 2025-Q4 | 5 | 99.74 | 0.65 | 99.90 | +0.16 | |
| QSC-2511-M7650 | Retatrutide | 01 Nov 2025 | 2026-Q1 | 1 | 99.68 | n<2 | 99.67 | -0.01 | |
| QSC-2511-K7380 | GHRP-6 | 01 Nov 2025 | 2025-Q4 | 2 | 99.64 | 0.48 | 99.90 | +0.26 | |
| QSC-2510-H7626 | Retatrutide | 24 Oct 2025 | 2026-Q1 | 3 | 97.90 | 0.69 | 99.00 | +1.10 | |
| QSC-2510-J9685 | BPC-157 | 19 Oct 2025 | 2026-Q1 | 8 | 99.49 | 0.67 | 99.90 | +0.41 | |
| QSC-2510-D8660 | Tirzepatide | 09 Oct 2025 | 2025-Q4 | 5 | 99.04 | 0.97 | 99.90 | +0.86 | |
| QSC-2509-Y7423 | Semaglutide | 29 Sep 2025 | 2026-Q1 | 2 | 99.40 | 0.63 | 99.62 | +0.22 | |
| QSC-2509-J8436 | ARA-290 | 19 Sep 2025 | 2025-Q4 | 1 | 98.39 | n<2 | 99.90 | +1.51 | |
| QSC-2509-E9456 | Survodutide | 07 Sep 2025 | 2026-Q1 | 1 | 99.67 | n<2 | 99.50 | -0.17 | |
| QSC-2508-D7983 | CJC-1295 (no DAC) | 31 Aug 2025 | 2026-Q1 | 2 | 99.39 | 0.42 | 99.76 | +0.37 | |
| QSC-2508-B8479 | AOD-9604 | 28 Aug 2025 | 2025-Q3 | 10 | 99.38 | 0.69 | 99.90 | +0.52 | |
| QSC-2508-F6725 | GHRP-6 | 27 Aug 2025 | 2025-Q4 | 14 | 99.93 | 0.64 | 99.90 | -0.03 | |
| QSC-2508-F9226 | Semaglutide | 22 Aug 2025 | 2026-Q1 | 10 | 99.37 | 1.26 | 99.90 | +0.53 | |
| QSC-2508-K7452 | GHRP-6 | 07 Aug 2025 | 2025-Q4 | 1 | 99.93 | n<2 | 100.50 | +0.57 | |
| QSC-2508-X9836 | Ipamorelin | 03 Aug 2025 | 2025-Q4 | 3 | 99.40 | 0.51 | 99.90 | +0.50 | |
| QSC-2507-F6894 | MK-677 (Ibutamoren mesylate) | 25 Jul 2025 | 2025-Q3 | 3 | 99.50 | 0.41 | 99.89 | +0.39 | |
| QSC-2507-J7717 | TB-500 | 12 Jul 2025 | 2025-Q4 | 9 | 99.93 | 0.53 | 99.90 | -0.03 | |
| QSC-2506-M9170 | Ipamorelin | 23 Jun 2025 | 2025-Q3 | 1 | 99.58 | n<2 | 99.90 | +0.32 | |
| QSC-2506-B8101 | Survodutide | 07 Jun 2025 | 2025-Q4 | 6 | 98.93 | 0.96 | 98.87 | -0.06 | |
| QSC-2505-B8934 | TB-500 | 24 May 2025 | 2025-Q3 | 9 | 99.66 | 0.91 | 99.90 | +0.24 | |
| QSC-2505-C7889 | TB-500 | 13 May 2025 | 2025-Q4 | 9 | 99.13 | 1.38 | 99.87 | +0.74 | |
| QSC-2505-G7853 | Ipamorelin | 08 May 2025 | 2025-Q4 | 1 | 99.84 | n<2 | 99.82 | -0.02 | |
| QSC-2505-N8999 | Desmopressin | 01 May 2025 | 2025-Q3 | 12 | 99.62 | 0.62 | 99.90 | +0.28 | |
| QSC-2504-T7980 | TB-500 | 28 Apr 2025 | 2025-Q2 | 10 | 99.85 | 0.51 | 99.90 | +0.05 | |
| QSC-2504-R9199 | Retatrutide | 01 Apr 2025 | 2025-Q3 | 10 | 98.93 | 1.39 | 99.50 | +0.57 | |
| QSC-2503-U9441 | Semaglutide | 28 Mar 2025 | 2025-Q2 | 2 | 98.97 | 0.07 | 99.61 | +0.64 | |
| QSC-2503-D8324 | Melanotan II | 09 Mar 2025 | 2025-Q3 | 2 | 99.34 | 1.19 | 100.50 | +1.16 | |
| QSC-2502-P6653 | Tirzepatide | 25 Feb 2025 | 2025-Q3 | 1 | 98.38 | n<2 | 98.72 | +0.34 | |
| QSC-2502-M9247 | Liraglutide | 18 Feb 2025 | 2025-Q1 | 5 | 99.19 | 0.53 | 99.69 | +0.50 | |
| QSC-2502-M8050 | SS-31 (Elamipretide) | 07 Feb 2025 | 2025-Q3 | 9 | 99.93 | 0.00 | 99.90 | -0.03 | |
| QSC-2502-D6580 | Retatrutide | 02 Feb 2025 | 2025-Q3 | 9 | 98.33 | 1.66 | 98.66 | +0.33 | |
| QSC-2502-N9962 | Selank | 01 Feb 2025 | 2025-Q2 | 1 | 99.81 | n<2 | 99.90 | +0.09 | |
| QSC-2501-L7062 | Enclomiphene citrate | 30 Jan 2025 | 2025-Q2 | 4 | 99.75 | 0.67 | 99.90 | +0.15 | |
| QSC-2412-D8748 | BPC-157 | 25 Dec 2024 | 2025-Q1 | 11 | 99.31 | 1.02 | 99.73 | +0.42 | |
| QSC-2412-W8004 | Kisspeptin-10 | 06 Dec 2024 | 2025-Q1 | 9 | 99.57 | 0.84 | 99.90 | +0.33 | |
| QSC-2412-F7396 | Semaglutide | 01 Dec 2024 | 2025-Q2 | 5 | 98.95 | 1.88 | 99.18 | +0.23 | |
| QSC-2411-X7470 | TB-500 | 24 Nov 2024 | 2025-Q1 | 12 | 99.90 | 0.59 | 99.90 | 0.00 | |
| QSC-2411-D9076 | CJC-1295 (no DAC) | 12 Nov 2024 | 2025-Q1 | 3 | 98.64 | 0.68 | 99.74 | +1.10 | |
| QSC-2411-C8332 | Retatrutide | 10 Nov 2024 | 2024-Q4 | 6 | 98.44 | 0.97 | 98.58 | +0.14 | |
| QSC-2410-R7035 | Tirzepatide | 26 Oct 2024 | 2025-Q1 | 12 | 99.37 | 1.16 | 100.00 | +0.63 | |
| QSC-2410-L8549 | CJC-1295 (no DAC) | 19 Oct 2024 | 2024-Q4 | 2 | 98.43 | 0.44 | 98.74 | +0.31 | SHARED BULK |
| QSC-2410-P7940 | Semaglutide | 04 Oct 2024 | 2024-Q4 | 8 | 98.94 | 1.04 | 99.85 | +0.91 | |
| QSC-2408-X8779 | Retatrutide | 29 Aug 2024 | 2024-Q4 | 9 | 98.52 | 0.97 | 99.39 | +0.87 | |
| QSC-2408-T6517 | Tirzepatide | 24 Aug 2024 | 2025-Q1 | 7 | 99.73 | 0.53 | 100.00 | +0.27 | |
| QSC-2408-D7316 | Semaglutide | 11 Aug 2024 | 2024-Q3 | 11 | 99.15 | 1.23 | 99.85 | +0.70 | |
| QSC-2407-F9884 | Afamelanotide | 14 Jul 2024 | 2024-Q3 | 12 | 99.93 | 0.38 | 99.90 | -0.03 | |
| QSC-2406-G6717 | AOD-9604 | 15 Jun 2024 | 2024-Q3 | 8 | 99.92 | 0.14 | 99.90 | -0.02 | |
| QSC-2405-W6407 | GHRP-6 | 31 May 2024 | 2024-Q3 | 1 | 99.93 | n<2 | 99.84 | -0.09 | |
| QSC-2405-U7656 | IGF-1 LR3 | 14 May 2024 | 2024-Q3 | 1 | 98.56 | n<2 | 99.72 | +1.16 | |
| QSC-2405-A6223 | L-Glutathione (reduced) | 09 May 2024 | 2024-Q3 | 2 | 99.81 | 0.25 | 99.90 | +0.09 | |
| QSC-2404-P8297 | Retatrutide | 15 Apr 2024 | 2024-Q2 | 14 | 98.62 | 1.33 | 99.52 | +0.90 | SHARED BULK |
| QSC-2403-Y8722 | Epitalon | 07 Mar 2024 | 2024-Q3 | 2 | 99.82 | 0.23 | 99.90 | +0.08 | |
| QSC-2402-T8543 | Kisspeptin-10 | 21 Feb 2024 | 2024-Q1 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| QSC-2402-H8701 | Tirzepatide | 21 Feb 2024 | 2024-Q1 | 9 | 99.20 | 1.26 | 99.86 | +0.66 | |
| QSC-2402-L8184 | Melanotan II | 17 Feb 2024 | 2024-Q1 | 3 | 99.70 | 0.53 | 99.90 | +0.20 | |
| QSC-2402-D9020 | Tirzepatide | 14 Feb 2024 | 2024-Q1 | 3 | 98.91 | 0.25 | 99.07 | +0.16 | |
| QSC-2402-G9476 | Melanotan II | 12 Feb 2024 | 2024-Q3 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| QSC-2402-U8375 | MOTS-c | 03 Feb 2024 | 2024-Q3 | 13 | 99.93 | 0.51 | 99.90 | -0.03 | |
| QSC-2402-X7410 | PT-141 (Bremelanotide) | 02 Feb 2024 | 2024-Q1 | 12 | 99.60 | 1.19 | 99.90 | +0.30 | |
| QSC-2401-S7715 | TB-500 | 18 Jan 2024 | 2024-Q1 | 1 | 99.46 | n<2 | 99.90 | +0.44 | |
| QSC-2311-E9215 | TB-500 | 08 Nov 2023 | 2024-Q1 | 3 | 99.76 | 0.21 | 99.90 | +0.14 |